Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tio RA, van der Giessen WJ, Marques KM, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Biemond BJ, Tijssen JG, van Rossum AC, Piek JJ, Zijlstra F. Hirsch A, et al. Among authors: van rossum ac, van der vleuten pa, van der giessen wj. Catheter Cardiovasc Interv. 2008 Feb 15;71(3):273-81. doi: 10.1002/ccd.21337. Catheter Cardiovasc Interv. 2008. PMID: 18288734 Clinical Trial.
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
Hirsch A, Nijveldt R, van der Vleuten PA, Tijssen JG, van der Giessen WJ, Tio RA, Waltenberger J, ten Berg JM, Doevendans PA, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Piek JJ, Zijlstra F; HEBE Investigators. Hirsch A, et al. Among authors: van rossum ac, van der vleuten pa, van der giessen wj. Eur Heart J. 2011 Jul;32(14):1736-47. doi: 10.1093/eurheartj/ehq449. Epub 2010 Dec 10. Eur Heart J. 2011. PMID: 21148540 Clinical Trial.
Bone marrow cell therapy after acute myocardial infarction: the HEBE trial in perspective, first results.
van der Laan A, Hirsch A, Nijveldt R, van der Vleuten PA, van der Giessen WJ, Doevendans PA, Waltenberger J, Ten Berg JM, Aengevaeren WR, Zwaginga JJ, Biemond BJ, van Rossum AC, Tijssen JG, Zijlstra F, Piek JJ. van der Laan A, et al. Among authors: van rossum ac, van der vleuten pa, van der giessen wj. Neth Heart J. 2008 Dec;16(12):436-9. doi: 10.1007/BF03086194. Neth Heart J. 2008. PMID: 19127324 Free PMC article.
Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
Hirsch A, Windhausen F, Tijssen JG, Oude Ophuis AJ, van der Giessen WJ, van der Zee PM, Cornel JH, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable coronary Syndromes Investigators. Hirsch A, et al. Among authors: van der zee pm, van der giessen wj. Eur Heart J. 2009 Mar;30(6):645-54. doi: 10.1093/eurheartj/ehn438. Epub 2008 Sep 29. Eur Heart J. 2009. PMID: 18824461 Clinical Trial.
Elective sirolimus-eluting stent implantation for left main coronary artery disease: six-month angiographic follow-up and 1-year clinical outcome.
Arampatzis CA, Lemos PA, Hoye A, Saia F, Tanabe K, van der Giessen WJ, Smits PC, McFadden E, de Feyter P, Serruys PW. Arampatzis CA, et al. Among authors: van der giessen wj. Catheter Cardiovasc Interv. 2004 Jul;62(3):292-6; discussion 297. doi: 10.1002/ccd.20064. Catheter Cardiovasc Interv. 2004. PMID: 15224292
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Among authors: van der ent m, van domburg r, van mieghem ca, van der giessen wj. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
Elective sirolimus-eluting stent implantation for multivessel disease involving significant LAD stenosis: one-year clinical outcomes of 99 consecutive patients--the Rotterdam experience.
Arampatzis CA, Hoye A, Lemos PA, Saia F, Tanabe K, Degertekin M, Sianos G, Smits PC, van der Giessen WJ, McFadden E, van Domburg R, de Feyter P, Serruys PW. Arampatzis CA, et al. Among authors: van domburg r, van der giessen wj. Catheter Cardiovasc Interv. 2004 Sep;63(1):57-60. doi: 10.1002/ccd.20073. Catheter Cardiovasc Interv. 2004. PMID: 15343568
295 results